Screening for celiac disease in patients with deletion 22q11.2 (DiGeorge/velo‐cardio‐facial syndrome)
M. Digilio,B. Marino,A. Giannotti,M. Castro,F. Colistro,F. Ferretti,B. Dallapiccola
DOI: https://doi.org/10.1002/ajmg.a.20254
2003-09-01
Abstract:The DiGeorge/velo-cardio-facial syndrome (DG/ VCFS) is characterized by minor facial anomalies, conotruncal heart defect, palatal anomalies, immunological deficit, and neonatal hypocalcemia [Lipson et al., 1991; Wilson et al., 1993; Ryan et al., 1997]. Most of the cases of DG/VCFS are due to a microdeletion of chromosome 22q11.2 (del22q11.2) [Scambler et al., 1991; Driscoll et al., 1993]. This chromosomal anomaly is considered to be among the most frequent causes of genetic syndromes with an estimated incidence of 1/4,000 livebirths [Devriendt et al., 1998]. Gastrointestinal symptoms occur in patients with DG/VCFS in the first years of life [Goldberg et al., 1993; Ryan et al., 1997; Piccoli, 2000]. Particularly, feeding difficulties are considered to be due to dysmotility of the pharyngoesophageal area, which is derived from the third and fourth pharyngeal arches involved in the pathogenesis of the syndrome [McDonald-McGinn et al., 1999; Rommel et al., 1999; Vantrappen et al., 1999]. Feeding problems seem to be the prevalent cause of underweight in the first years of age of DG/VCFS patients; weight growth improves when feeding difficulties become uncommon [Digilio et al., 2001]. To our knowledge, celiac disease (CD) has never been reported in patients with DG/VCFS. But, several other chromosomal syndromes are frequently associated with CD. In fact, screening for CD has been recommended in patients with Down syndrome [Castro et al., 1993; George et al., 1996], Turner syndrome [Bonamico et al., 1998; Ivarsson et al., 1999], and Williams syndrome [Giannotti et al., 2001], since the prevalence of CD in these conditions ranges between 4.5 and 10.5%. The analysis of clinical symptoms has shown an atypical or silent CD in subjects with these syndromes, and the screening tests for CD are considered to be of primary importance in identifying patients who should undergo jejunal biopsy. Considering the high prevalence of CD in these chromosomal abnormalities, we carried out a screening for CD in patients with DG/VCFS, to determine if del22q11.2 could be another condition at risk for CD. Autoimmune disorders, including juvenile rheumatoid arthritis [Rasmussen et al., 1996; Sullivan et al., 1997; Verloes et al., 1998], Graves disease [Pong et al., 1985], and hemolytic anemia [Sherry et al., 1990] have been reported in patients with del22q11.2. Thus, it is possible that other autoimmune disorders are present with increased frequency in patients with del22q11.2. From January 1997 to June 2001, 48 children with DG/VCFS above the age of 18 months underwent a screening forCD in the setting of a follow-upprogram for the syndrome.Therewere28boysand20girls. Their age at time of the screening ranged from 1.8 to 15.5 years (mean SD 5.89 3.84 years). Most patients (43/481⁄4 90%) were more than the age of 3 years. All patients had typical clinical characteristics of the syndrome. The clinical diagnosis of DG/VCFS was confirmed by Fluorescent in situ hybridization (FISH) with Sc11.1 and Co23 probes [Dallapiccola et al., 1996] demonstrating the del22q11.2. All patients were receiving a gluten-containing diet. Anamnestic informations about signs and symptoms in relation to a malabsorption condition were investigated by interview. In particular, the presence of chronic diarrhea, feeding difficulties, and abdominal pain were studied. Weight and height parameters at the time of the screening were recorded and plotted on standard percentile growth charts by Tanner et al. [1966]. Serum immunoglobulins IgA were measured. Antigliadin antibodies (AGA) IgA were studied by enzyme immunoassay (Pharmacia Diagnostic AB, Uppsala, Sweden). A test was considered positive if the sample result was >35 AU. Antiendomysium antibodies (AEA) IgA were determined by indirect immunofluorescence on a section of the lower third of oesophagus of the monkey. The dilution of serum was 1:5. Sera showing fluorescence in the endomysial lining of smooth muscle fibers at 1/5 or higher were considered positive. In presence of positivity of AEA IgA, small-bowel biopsy with Watson’s capsule or during endoscopy was performed. The diagnosis of CD was made when villous atrophy with hyperplasia of the crypts and increased *Correspondence to: Dr. Maria Cristina Digilio, Medical Genetics, Bambino Gesu Hospital, Piazza S. Onofrio 4, 00165 Rome, Italy. E-mail: digilio@opbg.net